Stock On the Run: Callon Petroleum Company (NYSE:CPE)

Lloyd Doyle
December 8, 2017

The stock's short float is around of 21.83% and short ratio is 7.68. Cna Finl Corp now has $14.59B valuation. The stock decreased 1.35% or $0.15 during the last trading session, reaching $10.61. The NYSE-listed company saw a recent bid of $24.99 on volume of 6.44 million shares. Tokio Marine Asset Mngmt holds 0.1% of its portfolio in Callon Petroleum Company (NYSE:CPE) for 64,200 shares. It has underperformed by 4.41% the S&P500. The Bb Biotech Ag holds 777,500 shares with $23.41M value, up from 727,500 last quarter. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell. Therefore 100% are positive. CNA Financial had 8 analyst reports since October 16, 2015 according to SRatingsIntel. The firm has "Buy" rating given on Thursday, May 26 by Wunderlich. As per Wednesday, November 18, the company rating was initiated by Goldman Sachs. The firm has "Neutral" rating by Macquarie Research given on Friday, December 2. The stock has "Hold" rating by Cowen & Co on Monday, June 19. The firm has "Buy" rating given on Wednesday, August 2 by BMO Capital Markets. The stock of Seattle Genetics, Inc. The firm has "Buy" rating by SunTrust given on Tuesday, October 3.

Investors sentiment decreased to 1.73 in Q2 2017. Its down 0.20, from 1.5 in 2017Q1. It fall, as 36 investors sold FPRX shares while 38 reduced holdings. California Employees Retirement Systems accumulated 0% or 20,800 shares. 1St Glob Advsrs reported 33,366 shares. 6,487 were accumulated by Parametrica Mgmt Ltd. Northwestern Mutual Wealth Management reported 0% in Seattle Genetics, Inc. Northern Tru Corporation owns 0% invested in Five Prime Therapeutics, Inc. 2,379 were accumulated by Point72 Asia (Hong Kong) Limited. Viking Fund Mngmt Limited, North Dakota-based fund reported 1.14 million shares. Tekla Capital Mngmt has 223,700 shares. Oakworth Inc stated it has 0% of its portfolio in Five Prime Therapeutics, Inc. Morgan Stanley invested in 0% or 83,637 shares.

Seattle Genetics, Inc., a biotechnology company, develops and commercializes targeted therapies to treat cancer worldwide. The company has market cap of $2.14 billion. It now has negative earnings. Therefore 93% are positive.

Taking a broader look brokerage firms' analysts on the street with an expectant view have Callon Petroleum Company (NYSE:CPE) high price target of $22 and with a conservative view have low price target of $10.

Over the past three months, Callon Petroleum Company insiders have been net buyers, dumping a net of 0 shares.

Callon Petroleum (NYSE:CPE) last issued its quarterly earnings results on Monday, November 6th. (NASDAQ:FPRX) has "Outperform" rating given on Thursday, January 21 by Credit Suisse. The firm earned "Hold" rating on Monday, September 18 by Keefe Bruyette & Woods. One analyst has rated the stock with a sell rating, four have issued a hold rating and twenty-two have given a buy rating to the company. As per Thursday, April 13, the company rating was upgraded by Euro Pacific Capital.

According to analysts Callon Petroleum Company (NYSE:CPE)'s minimum EPS for the current quarter is at $-0.04 and can go high up to $0.21. Insider ownership during the a year ago has decreased by a net of 452433 shares.

Previously Callon Petroleum Company (NYSE:CPE) reported $0.09 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.09 by $0.

Investors sentiment decreased to 1.73 in Q2 2017. Its down 0.13, from 0.83 in 2017Q1.

A number of institutional investors have recently added to or reduced their stakes in CPE. Goldman Sachs Gp holds 211,056 shares or 0% of its portfolio. Riverhead Management Llc accumulated 17,050 shares or 0.04% of the stock. (NASDAQ:FPRX) for 8,200 shares. Panagora Asset Mgmt Incorporated invested in 2,861 shares. Natl Bank Of Montreal Can invested in 0% or 39,028 shares.

Callon Petroleum Company (NYSE:CPE) gained 0.26 Percent and closed its previous trading session at $11.37. Guggenheim Capital Ltd Liability Co reported 0% in Callon Petroleum Company (NYSE:CPE). To measure price-variation, we found CPE's volatility during a week at 4.2% and during a month it has been found around 3.96%. Citigroup initiated the shares of FPRX in report on Friday, July 31 with "Buy" rating. The company made Return on equity of 4.90% in last 12 months period. Gabelli Funds Ltd Liability owns 284,000 shares.

KAYNE ANDERSON CAPITAL ADVISORS LP lowered its stake in Enterprise Products Partners L.P. (NYSE:EPD) by 0.28% during the September 2017 quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Other reports by Iphone Fresh

Discuss This Article